Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001628280-24-052494
Filing Date
2024-12-27
Accepted
2024-12-27 16:01:02
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 quincetherapeutics-424b5.htm 424B5 167908
2 quincea.jpg GRAPHIC 11131
  Complete submission text file 0001628280-24-052494.txt   184499
Mailing Address 611 GATEWAY BLVD., SUITE 273 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 273 SOUTH SAN FRANCISCO CA 94080 415-910-5717
Quince Therapeutics, Inc. (Filer) CIK: 0001662774 (see all company filings)

EIN.: 901024039 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-283897 | Film No.: 241585703
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)